Sahar M. El‐Haggar

Pentoxifylline, a nonselective phosphodiesterase inhibitor, in adjunctive therapy in patients with irritable bowel syndrome treated with mebeverine

Sahar M. El‐Haggar, Sahar K. Hegazy, Sherief Abd‐Elsalam et al. · Biomedicine & Pharmacotherapy · 2021 · 18 citations · Full text

Pentoxifylline in patients with ulcerative colitis treated with mesalamine by modulation of IL-6/STAT3, ZO-1, and S1P pathways: a randomized controlled double-blinded study

Mostafa M. Bahaa, Sahar K. Hegazy, M Maher et al. · Inflammopharmacology · 2024 · 17 citations

Inflammation, Anti-inflammatory, Autoimmune Disease +8

Metformin as adjuvant therapy in obese knee osteoarthritis patients

Amany Abd Elaal Aiad, Sahar M. El‐Haggar, Amal Mohamad El‐Barbary et al. · Inflammopharmacology · 2024 · 16 citations · Full text

Open‐label pilot study of ethosuximide as adjunctive therapy for relieving abdominal pain related to Irritable Bowel Syndrome

Sahar M. El‐Haggar, Sahar K. Hegazy, Sherief Abd‐Elsalam et al. · Journal of Clinical Pharmacy and Therapeutics · 2021 · 12 citations

Possible protective effect of rosuvastatin in chemotherapy-induced cardiotoxicity in HER2 positive breast cancer patients: a randomized controlled trial

Khlood M. Kettana, Sahar M. El‐Haggar, Mohamed A. Alm El‐Din et al. · Medical Oncology · 2024 · 11 citations · Full text